| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alector, Inc. (ALEC) has 11 insiders with recent SEC Form 4 filings, including 6 buys and 4 sells. ALEC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.42M | $4.31M | - | |
| Pres | 501.7K | $892.9K | - | |
| CFO | 374.3K | $666.3K | - | |
| Dir | 128.1K | $228.0K | - | |
| Other | 104.6K | $186.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2019 | King Robert76 | Chief Development Officer | Sell | 7,500 | $15.00 | $112,500.00 | -1.4% | |
| Aug 15, 2019 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $14.19 | $141,900.00 | -3.0% | |
| Aug 7, 2019 | Orbimed Advisors LLC67 | 10% Owner | Sell | 650,000 | $17.90 | $11,635,000.00 | -5.0% | |
| Feb 11, 2019 | Gordon Carl L74 | Director, 10% Owner | Buy | 411,700 | $19.00 | $7,822,300.00 | +3.2% | |
| Feb 11, 2019 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 411,700 | $19.00 | $7,822,300.00 | +3.2% |